Stock Comparison
LLY vs NVS
Eli Lilly and Company and Novartis AG ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$1.04T
$287.36B
P/E (TTM)
39.1
22.9
Forward P/E
32.1
16.9
Price/Sales
13.0
5.1
Price/Book
30.6
6.9
EV/EBITDA
26.0
14.5
Dividend Yield
0.53%
3.15%
Profitability
Net Margin
33.53%
24.14%
Operating Margin
43.92%
30.54%
Return on Equity
102.30%
30.30%
Return on Assets
20.40%
10.20%
Growth (YoY)
Revenue Growth
47.70%
0.80%
Earnings Growth
26.20%
-17.00%
Price & Risk
Beta
0.5
0.5
52-Week High
$1,235.65
$163.61
52-Week Low
$679.67
$118.18
Analyst Target
$1,297.31
$155.37
Compare LLY and NVS your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.